Latest Breaking News On - உறுப்பினர் ஆஃப் தி அரச கல்லூரி மருத்துவர்கள் - Page 1 : comparemela.com

Feb 16 2021 Read 304 Times Dr Gerard Short, MBBS has joined biotech VarmX, a company focusing on innovative approaches for the reversal of anticoagulation, as Chief Medical Officer (CMO). He will be responsible for overseeing the clinical development of the company’s pipeline, including progression of its lead product, VMX-C001, into clinical proof of concept and registrational studies. With more than 20 years working with both big pharma and biotechs, Dr Short’s clinical development expertise has a particular focus on rare diseases and gene therapy for haematological disorders. He joins VarmX from Freeline Therapeutics, where he served for five years as SVP Clinical and Regulatory and later SVP Medical Science, establishing an in-house pharmacovigilance function and advancing gene therapy clinical programmes in haemophilia B and Fabry’s disease. During a decade at Genzyme, he led the Global Development Team treatment programmes targeting Pompe’s disease (phase 3) and acut

United kingdomLondonCity ofAlexander vosLondon business schoolMember of the royal college physiciansImperial collegeNovartisPfizerMaster of business administrationMary hospital medical schoolGlobal development teamChief medical officerFreeline therapeuticsHospital medical schoolBusiness administration